S. Beslija: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

Barbell Hip-Thrust Exercise

Dello Iacono, Antonio, Padulo, Johnny, Bešlija, Tea, Halperin, Israel

Journal:

The Journal of Strength and Conditioning Research

Year:

2018

Language:

english

File:

PDF, 410 KB

english, 2018

2

Phase III, Open-Label, Randomized Study Comparing Concurrent Gemcitabine Plus Cisplatin and Radiation Followed by Adjuvant Gemcitabine and Cisplatin Versus Concurrent Cisplatin and Radiation in Patients With Stage IIB to IVA Carcinoma of the Cervix

Duenas-Gonzalez, A., Zarba, J. J., Patel, F., Alcedo, J. C., Beslija, S., Casanova, L., Pattaranutaporn, P., Hameed, S., Blair, J. M., Barraclough, H., Orlando, M.

Journal:

Journal of Clinical Oncology

Year:

2011

Language:

english

File:

PDF, 167 KB

english, 2011

3

Psychotherapy with Refugees from Bosnia–Herzegovina

Journal:

Transactional Analysis Journal

Year:

1997

Language:

english

File:

PDF, 747 KB

english, 1997

4

[IEEE 2016 IEEE International Power Modulator and High Voltage Conference (IPMHVC) - San Francisco, CA, USA (2016.7.6-2016.7.9)] 2016 IEEE International Power Modulator and High Voltage Conference (IPMHVC) - Calculation of the pressure rise caused by internal arc faults in HV metal-enclosed SF6 GIS

Beslija, Dejan, Delic, Sead, Kapetanovic, Mirsad, Gorenc, Dalibor

Year:

2016

Language:

english

File:

PDF, 452 KB

english, 2016

5

Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trial

Zielinski, Christoph, Láng, István, Inbar, Moshe, Kahán, Zsuzsanna, Greil, Richard, Beslija, Semir, Stemmer, Salomon M, Zvirbule, Zanete, Steger, Günther G, Melichar, Bohuslav, Pienkowski, Tadeusz, Si

Journal:

The Lancet Oncology

Year:

2016

Language:

english

File:

PDF, 612 KB

english, 2016

6

Safety results from a phase III study (TURANDOT trial by CECOG) of first-line bevacizumab in combination with capecitabine or paclitaxel for HER-2-negative locally recurrent or metastatic breast cancer

I. Lang, M.J. Inbar, Z. Kahán, R. Greil, S. Beslija, S.M. Stemmer, B. Kaufman, Z. Zvirbule, G.G. Steger, D. Messinger, T. Brodowicz, C. Zielinski

Journal:

European Journal of Cancer

Year:

2012

Language:

english

File:

PDF, 302 KB

english, 2012

7

Combined radio-chemotherapy (CR) in advanced cervical cancer: a phase-II trial with cisplatin and bleomycin

N. Kantardzic, S. Beslija, M. Musanovic, A. Cardzic, N. Kazic, N. Mahic, N. Paraganlija, J. Lomigoric, M. Banjin

Journal:

European Journal of Cancer

Year:

1999

Language:

english

File:

PDF, 161 KB

english, 1999

8

A phase II study of gemcitabine plus carboplatin in platinum-sensitive, recurrent ovarian carcinoma

M.F. Kose, J. Sufliarsky, S. Beslija, P. Saip, G. Tulunay, K. Krejcy, T. Minarik, E. Fitzthum, A. Hayden, A. Melemed

Journal:

Gynecologic Oncology

Year:

2005

Language:

english

File:

PDF, 166 KB

english, 2005

9

3068 POSTER Capecitabine + irinotecan + bevacizumab as first-line therapy for patients (pts) with metastatic colorectal cancer (MCRC): preliminary phase II study results

S. Beslija, M. Banjin, S. Jungic, N. Obralic, G. Kecman-Malcic, I. Rakita, B. Salkic, A. Pasic, L. Tinjic, E. Ajanovic

Journal:

European Journal of Cancer Supplements

Year:

2007

Language:

english

File:

PDF, 80 KB

english, 2007

10

Long-term outcome of GIST patients treated with delayed imatinib therapy

Kurtovic-Kozaric, Amina, Kugic, Amina, Hasic, Azra, Beslija, Semir, Ceric, Timur, Pasic, Anes, Vranic, Semir, Kopric, Dijana, Iljazovic, Ermina, Todorovic Barbuscia, Jelena, Kozaric, Mirza, Ibisevic,

Journal:

European Journal of Cancer

Year:

2017

Language:

english

File:

PDF, 463 KB

english, 2017

11

Managing an oncology clinic during the COVID-19 pandemicâhow we did it in Sarajevo?

Journal:

memo - Magazine of European Medical Oncology

Year:

2020

File:

PDF, 178 KB

2020

12

Clinicopathologic characteristics of invasive apocrine carcinoma of the breast: A single center experience from a country with limited resources

Imamovic, D., Bilalovic, N., Skenderi, F., Beslagic, V., Ceric, T., Hasanbegovic, B., Beslija, S., Vranic, S.

Journal:

European Journal of Cancer

Year:

2018

Language:

english

File:

PDF, 47 KB

english, 2018

13

ASCO 2019—Personal highlights on adjuvant breast cancer: (neo-)adjuvant therapy of HER2-negative HR-positive BC

Journal:

memo - Magazine of European Medical Oncology

Year:

2019

File:

PDF, 198 KB

2019

14

3046 POSTER A randomized, open-label phase II study evaluating the efficacy and safety of FOLFOX6 + Cetuximab versus FOLFIRI + Cetuximab as first-line therapy in patients with metastatic colorectal cancer

T.E. Ciuleanu, W. Scheithauer, G. Kurteva, J. Ocvirk, I. Koza, D. Papamichael, M. Wenczl, T. Brodowicz, C.C. Zielinski, S. Beslija

Journal:

European Journal of Cancer Supplements

Year:

2007

Language:

english

File:

PDF, 55 KB

english, 2007

15

409TiPPHASE III STUDY OF PALBOCICLIB IN COMBINATION WITH EXEMESTANE VS. CAPECITABINE, IN HORMONAL RECEPTOR (HR) POSITIVE/HER2 NEGATIVE METASTATIC BREAST CANCER (MBC) PATIENTS WITH RESISTANCE TO NON-STEROIDAL AROMATASE INHIBITORS (NSAI): PEARL STUDY (GEICAM/2013-02_CECOG/BC.1.3.006)

Martin, M., Beslija, S., Carrasco, E., Kahan, Z., Escudero, M.J., Láng, I., Bartlett, C.H., Bermejo, B., Inbar, M., Chacón, J.I., Jinga, D.C., García-Sáenz, J.A., Haba, J. De La, Koehler, M., Morales,

Journal:

Annals of Oncology

Year:

2014

File:

PDF, 67 KB

2014

16

[IEEE 2016 IEEE International Power Modulator and High Voltage Conference (IPMHVC) - San Francisco, CA, USA (2016.7.6-2016.7.9)] 2016 IEEE International Power Modulator and High Voltage Conference (IPMHVC) - Partial discharge measurements and IEC standards: Justification of the use for their inclusion in afterlaying test for extruded cable systems

Batalovic, Mirza, Beslija, Dejan, Kapetanovic, Mirsad, Kim, Myoung-Hoo, Kim, Kyong-Hoe

Year:

2016

Language:

english

File:

PDF, 660 KB

english, 2016

17

Clinicopathologic characteristics of invasive apocrine carcinoma of the breast: A single center experience from a country with limited resources

Imamovic, D., Bilalovic, N., Skenderi, F., Beslagic, V., Ceric, T., Hasanbegovic, B., Beslija, S., Vranic, S.

Journal:

European Journal of Cancer

Year:

2018

File:

PDF, 47 KB

2018

18

165 Gemcitabine (G) plus carboplatin (C) in patients whose epithelial ovarian carcinomas (EOC) relapsed ≥ 6 months after platinum-containing first-line therapy: Preliminary results of a phase II study

F. Kose, J. Sufliarsky, S. Beslija, P. Saip, K. Krejcy, T. Minarik, E. Fitzthum, G. Tulunay, A. Melemed

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 170 KB

english, 2003

19

1800 Final results for overall survival (OS), the primary endpoint of the CECOG TURANDOT prospective randomised trial evaluating bevacizumab-paclitaxel (BEV-PAC) vs BEV-capecitabine (CAP) for HER2-negative locally recurrent/metastatic breast cancer (LR/mBC)

Zielinski, C.C., Lang, I., Inbar, M., Kahan, Z., Greil, R., Beslija, S., Stemmer, S.M., Zvirbule, Z., Steger, G.G., Melichar, B., Pienkowski, T., Sirbu, D., Petruzelka, L., Eniu, A., Nisenbaum, B., Da

Journal:

European Journal of Cancer

Year:

2015

Language:

english

File:

PDF, 74 KB

english, 2015

20

Reliability, Sensitivity, and Minimal Detectable Change of a New Specific Climbing Test for Assessing Asymmetry in Reach Technique

Čular, Dražen, Dhahbi, Wissem, Kolak, Ivo, Dello Iacono, Antonio, Bešlija, Tea, Laffaye, Guillaume, Padulo, Johnny

Journal:

The Journal of Strength and Conditioning Research

Year:

2018

Language:

english

File:

PDF, 290 KB

english, 2018

21

Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses

Brodowicz, T, Lang, I, Kahan, Z, Greil, R, Beslija, S, Stemmer, S M, Kaufman, B, Petruzelka, L, Eniu, A, Anghel, R, Koynov, K, Vrbanec, D, Pienkowski, T, Melichar, B, Spanik, S, Ahlers, S, Messinger,

Journal:

British Journal of Cancer

Year:

2014

Language:

english

File:

PDF, 195 KB

english, 2014

22

[IEEE 2014 IEEE International Power Modulator and High Voltage Conference (IPMHVC) - Santa Fe, NM, USA (2014.6.1-2014.6.5)] 2014 IEEE International Power Modulator and High Voltage Conference (IPMHVC) - New approach to breakdown voltage estimation after interruption of capacitive currents

Delie, Sead, Beslija, Dejan, Muratovic, Mahir, Kim, Myoung-Hoo, Kapetanovic, Mirsad, Zildzo, Hamid

Year:

2014

Language:

english

File:

PDF, 323 KB

english, 2014

23

Gemcitabine, epirubicin and paclitaxel (GET) vs. 5-fluorouracil, epirubicin and cyclophosphamide (FEC) as first-line treatment in metastatic breast cancer: interim toxicity analysis of a randomised, multicenter phase iii trial of the Central European Cooperative Oncology Group (CECOG)

T. Brodowicz, S. Beslija, J. Cervek, Z. Mrsic-Krmpotic, I. Tchernozemsky, C. Wiltschke, N. Ghilezan, M. Grgic, J. Jassem, C. Zielinski

Journal:

European Journal of Cancer

Year:

2001

Language:

english

File:

PDF, 166 KB

english, 2001

24

Predictive role of hand–foot syndrome in patients receiving first-line capecitabine plus bevacizumab for HER2-negative metastatic breast cancer

Zielinski, Christoph, Lang, Istvan, Beslija, Semir, Kahan, Zsuzsanna, Inbar, Moshe J, Stemmer, Salomon M, Anghel, Rodica, Vrbanec, Damir, Messinger, Diethelm, Brodowicz, Thomas

Journal:

British Journal of Cancer

Year:

2015

Language:

english

File:

PDF, 264 KB

english, 2015

25

Validity and Reliability of the 30-s Continuous Jump for Anaerobic Power and Capacity Assessment in Combat Sport

Čular, Drazen, Ivančev, Vladimir, Zagatto, Alessandro M., Milić, Mirjana, Beslija, Tea, Sellami, Maha, Padulo, Johnny

Journal:

Frontiers in Physiology

Year:

2018

Language:

english

File:

PDF, 2.67 MB

english, 2018

26

Third consensus on medical treatment of metastatic breast cancer

Beslija, S., Bonneterre, J., Burstein, H. J., Cocquyt, V., Gnant, M., Heinemann, V., Jassem, J., Kostler, W. J., Krainer, M., Menard, S., Petit, T., Petruzelka, L., Possinger, K., Schmid, P., Stadtmau

Journal:

Annals of Oncology

Year:

2009

Language:

english

File:

PDF, 149 KB

english, 2009

27

[IEEE 2015 3rd International Conference on Electric Power Equipment – Switching Technology (ICEPE-ST) - Busan, South Korea (2015.10.25-2015.10.28)] 2015 3rd International Conference on Electric Power Equipment – Switching Technology (ICEPE-ST) - Capacitive current breaking capability estimation for a 145 kV 40 kA GIS circuit breaker

Delic, Sead, Beslija, Dejan, Gorenc, Dalibor, Hajdarovic, Armin, Kapetanovic, Mirsad

Year:

2015

Language:

english

File:

PDF, 884 KB

english, 2015

28

176PClinical outcomes of delayed start of trastuzumab treatment in patients with early breast cancer: ml25232 study

Beslija, S., Ceric, T., Hasanbegovic, B., Kurtovic-Kozaric, A., Pasic, A., Mahic, N., Kalamujic, M., Cardzic, A., Alidzanovic, J., Marjanovic, I., Mekic-Abazovic, A.

Journal:

Annals of Oncology

Year:

2017

Language:

english

File:

PDF, 50 KB

english, 2017

29

Breast cancer, locally advanced and metastatic

Zielinski, C., Lang, I., Inbar, M., Kahan, Z., Greil, R., Beslija, S., Stemmer, S. M., Kaufman, B., Zvirbule, Z., Steger, G., Melichar, B., Pienkowski, T., Sirbu, D., Petruzelka, L., Eniu, A., Nisenba

Journal:

Annals of Oncology

Year:

2012

Language:

english

File:

PDF, 419 KB

english, 2012

30

Second consensus on medical treatment of metastatic breast cancer

Beslija, S, Bonneterre, J, Burstein, H, Cocquyt, V, Gnant, M, Goodwin, P, Heinemann, V, Jassem, J, Kostler, W., Krainer, M, Menard, S, Petit, T, Petruzelka, L, Possinger, K, Schmid, P, Stadtmauer, E,

Journal:

Annals of Oncology

Year:

2006

Language:

english

File:

PDF, 117 KB

english, 2006

31

A clinicopathologic study of invasive apocrine carcinoma of the breast: A single-center experience

Imamovic, Denira, Bilalovic, Nurija, Skenderi, Faruk, Beslagic, Vanesa, Ceric, Timur, Hasanbegovic, Berisa, Beslija, Semir, Vranic, Semir

Journal:

The Breast Journal

Year:

2018

Language:

english

File:

PDF, 367 KB

english, 2018

32

Explosive Push-ups

Zalleg, Dalenda, Ben Dhahbi, Anis, Dhahbi, Wissem, Sellami, Maha, Padulo, Johnny, Souaifi, Marouen, Bešlija, Tea, Chamari, Karim

Journal:

The Journal of Strength and Conditioning Research

Year:

2018

Language:

english

File:

PDF, 303 KB

english, 2018

33

[IEEE 2019 5th International Conference on Electric Power Equipment - Switching Technology (ICEPE-ST) - Kitakyushu, Japan (2019.10.13-2019.10.16)] 2019 5th International Conference on Electric Power Equipment - Switching Technology (ICEPE-ST) - Algebra of Fractal Vector as a Tool for Mapping Two Different Mashes

Smajkic, Amer, Delic, Sead, Beslija, Dejan, Kim, Kyong Hoe, Kapetanovic, Mirsad

Year:

2019

Language:

english

File:

PDF, 1.89 MB

english, 2019

34

P-189 * Correlation between of expression of the enzyme topoisomerase I and p53 and result of irinotecan based therapy in patients with metastatic colorectal cancer

Pasic, A., Beslija, S., Djuran, A., Sefic-Pasic, I., Banjin, M., Ceric, T., Rasic, A., Hasanbegovic, B., Jalovcic, A., Kapisazovic, E.

Journal:

Annals of Oncology

Year:

2015

Language:

english

File:

PDF, 30 KB

english, 2015

35

G3 A phase III study comparing concurrent gemcitabine (Gem) plus cisplatin (Cis) and radiation followed by adjuvant Gem plus Cis versus concurrent Cis and radiation in patients with stage IIB to IVA carcinoma of the cervix

A. Dueñas-González, J.J. Zarba, J.C. Alcedo, P. Pattarunataporn, S. Beslija, F. Patel, L. Casanova, H. Barraclough, M. Orlando

Journal:

European Journal of Cancer Supplements

Year:

2009

Language:

english

File:

PDF, 49 KB

english, 2009

36

5058 Bevacizumab (Bev) combined with either capecitabine (X) or weekly paclitaxel (Pac) as first-line therapy for HER2-negative locally recurrent or metastatic breast cancer (LR/MBC): the CECOG phase III TURANDOT trial

I. Lang, M. Inbar, G. Steger, R. Greil, Z. Zvirbule, S. Beslija, Z. Kahán, V. Taskova, B. Kaufmann, C.C. Zielinski

Journal:

European Journal of Cancer Supplements

Year:

2009

Language:

english

File:

PDF, 68 KB

english, 2009

37

200PEffects of delayed initiation of adjuvant trastuzumab for non-metastatic, HER2 positive breast cancer in a limited resources setting: ML25232 study final results

Beslija, S, Ceric, T, Hasanbegovic, B, Skenderi, F, Alidžanović, J, Kopric, D, Marjanović, I, Mekic-Abazovic, A, Sisic, I S, Hammami, M, Pasic, A, Rasic, A, Kapisazović, E

Journal:

Annals of Oncology

Year:

2019

Language:

english

File:

PDF, 77 KB

english, 2019

38

Although higher expression of bcl-2 is associated with better outcome, bcl-2 is not an independent prognosticator of distant disease free survival (DDFS) or overall survival (OS) in breast cancer

S Hasanagic, S Vranic, S Beslija, I Selak, N Bilalovic

Journal:

European Journal of Cancer Supplements

Year:

2004

Language:

english

File:

PDF, 162 KB

english, 2004

39

Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer: interim efficacy results of the randomised, open-label, non-inferiority, phase 3 TURANDOT trial

Lang, Istvan, Brodowicz, Thomas, Ryvo, Larisa, Kahan, Zsuzsanna, Greil, Richard, Beslija, Semir, Stemmer, Salomon M, Kaufman, Bella, Zvirbule, Zanete, Steger, Günther G, Melichar, Bohuslav, Pienkowski

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 420 KB

english, 2013

40

5053 POSTER Randomized Phase III Study of First-line Bevacizumab in Combination With Capecitabine or Paclitaxel for HER2-negative LR/MBC: Interim Safety Data

Inbar, M., Lang, I., Kahán, Z., Greil, R., Beslija, S., Stemmer, S.M., Kaufman, B., Zvirbule, Z., Steger, G.G., Zielinski, C.C.

Journal:

European Journal of Cancer

Year:

2011

Language:

english

File:

PDF, 42 KB

english, 2011

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски